Organic sodium salts
- (1)
- (8)
- (7)
- (1)
- (3)
- (1)
- (1)
- (36)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (6)
- (1)
- (2)
- (1)
- (28)
- (2)
- (1)
- (6)
- (1)
- (3)
- (3)
- (13)
- (3)
- (2)
- (30)
- (4)
- (1)
- (2)
- (1)
- (1)
- (5)
- (3)
- (4)
- (4)
- (3)
- (1)
- (6)
- (6)
- (2)
- (2)
- (1)
- (2)
- (3)
- (1)
- (6)
- (5)
- (3)
- (1)
- (2)
- (1)
- (3)
- (2)
- (2)
- (1)
- (1)
- (3)
- (4)
- (10)
- (11)
- (3)
- (4)
- (9)
- (8)
- (2)
- (1)
- (3)
- (3)
- (9)
- (4)
- (3)
- (5)
- (3)
- (8)
- (4)
- (6)
- (2)
- (2)
- (4)
- (2)
- (4)
- (4)
- (1)
- (2)
- (7)
- (2)
- (3)
- (3)
- (3)
- (3)
- (1)
- (16)
- (13)
- (17)
- (20)
- (1)
- (18)
- (2)
- (1)
- (4)
- (2)
- (3)
- (34)
- (2)
- (12)
- (6)
- (2)
- (11)
- (18)
- (3)
- (1)
- (14)
- (2)
- (3)
- (2)
- (2)
- (1)
- (5)
- (5)
- (1)
- (5)
- (22)
- (24)
Filtered Search Results
eMolecules 865-47-4 | Potassium tert-butoxide | Oakwood Chemical | MFCD00012162 | 112.213 | C4H9KO | 99.000 | [K+].CC(C)(C)[O-] | 1kg | 537698671
Potassium tert-butoxide | Oakwood Chemical | 865-47-4 | MFCD00012162 | 112.213 | C4H9KO | 99.000 | [K+].CC(C)(C)[O-] | 1kg | 537698671
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Apexbio Technology LLC NBQX 118876-58-7 10mg
NBQX (CAS 118876-58-7) is a potent and selective antagonist of AMPA-type ionotropic glutamate receptors By inhibiting AMPA-mediated excitatory synaptic transmission NBQX disrupts glutamate-induced neuronal signaling thereby attenuating neuronal injury associated with excessive neurotransmitter release This compound has been widely utilized in preclinical studies to investigate neuroprotective and anticonvulsant mechanisms as well as to model and analyze the pathophysiology of neurodegenerative diseases epilepsy and other central nervous system disorders
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Apexbio Technology LLC CNQX 115066-14-3 10mg
CNQX (CAS 115066-14-3) is a selective and competitive antagonist of AMPA and kainate subtype ionotropic glutamate receptors In hippocampal slice preparations superfusion with CNQX at concentrations of 2 5 M reversibly inhibits excitatory post-synaptic potentials mediated by Schaffer collaterals and mossy fibers while preserving both fast and slow GABAergic inhibitory responses In behavioral studies bilateral infusion of CNQX into the amygdala or dorsal hippocampus prior to testing partially suppresses the expression of conditioned avoidance responses with complete blockade observed at specific doses CNQX is widely utilized to dissect excitatory synaptic transmission and investigate non-NMDA receptor functions in neurophysiological and behavioral research
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 2414-98-4 | Magnesium ethoxide | Oakwood Chemical | MFCD00009060 | 114.427 | C4H10MgO2 | 98.000 | [Mg++].CC[O-].CC[O-] | 25g | 537707801
Magnesium ethoxide | Oakwood Chemical | 2414-98-4 | MFCD00009060 | 114.427 | C4H10MgO2 | 98.000 | [Mg++].CC[O-].CC[O-] | 25g | 537707801
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC MEDCHEMEXPRESS LLC
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
5000286139 CNQX 10MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 1907-33-1 | Lithium tert-butoxide | Oakwood Chemical | MFCD00050479 | 80.060 | C4H9LiO | 0.000 | [Li+].CC(C)(C)[O-] | 5g | 703157388
Lithium tert-butoxide | Oakwood Chemical | 1907-33-1 | MFCD00050479 | 80.060 | C4H9LiO | 0.000 | [Li+].CC(C)(C)[O-] | 5g | 703157388
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC CNQX | 115066-14-3 | MFCD00069232 | C9H4N4O4 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
CNQX (FG9065) is a potent and competitive AMPA/kainate receptor antagonist with IC50s of 0.3 μM and 1.5 μM, respectively. It functions as a competitive non-NMDA receptor antagonist and has been shown to block the expression of fear-potentiated startle in rats.
- Potent and competitive AMPA/kainate receptor antagonist
- IC50s of 0.3 μM for AMPA and 1.5 μM for kainate
- Functions as a competitive non-NMDA receptor antagonist
- Blocks expression of fear-potentiated startle in rats
- Reversibly blocks Schaffer collateral and mossy fibre EPSP in hippocampal slices
- Selectively reduces amplitude of monosynaptic component of DR-VRR in lumbar spinal segments
- Decreases cocaine responses in a dose-dependent manner in rats
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC NBQX | 118876-58-7 | 99.8% | 336.28 | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. It possesses neuroprotective and anticonvulsant activity.
- Highly selective and competitive AMPA receptor antagonist.
- Exhibits neuroprotective activity.
- Has anticonvulsant activity.
- Decreases seizures.
- Neuroprotective in a focal ischaemia model.
- Has high affinity for AMPA and kainate binding sites.
- Shows little to no affinity for the glutamate recognition site on the NMDA receptor complex.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC NBQX (disodium) | 479347-86-9 | MFCD00220677 | C12H6N4Na2O6S | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
NBQX disodium (FG9202 disodium) is a highly selective and competitive AMPA receptor antagonist, known for its neuroprotective and anticonvulsant activities. This compound demonstrates a high affinity for AMPA and kainate binding sites, while showing minimal affinity for the glutamate recognition site on the NMDA receptor complex. Research indicates its effectiveness in protecting against focal ischaemia and reducing seizures in experimental models.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective properties
- Shows anticonvulsant efficacy
- Possesses high affinity for AMPA and kainate binding sites
- Low affinity for NMDA receptor complex
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC CNQX disodium | 479347-85-8 | C9H2N4Na2O4 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
CNQX disodium (FG9065 disodium) is a potent and competitive antagonist of AMPA/kainate receptors, exhibiting IC50s of 0.3 μM and 1.5 μM respectively. It also functions as a competitive non-NMDA receptor antagonist and has been observed to block the expression of fear-potentiated startle in rats. This compound is primarily utilized in research focused on neurological diseases and iGluR targets.
- Potent and competitive AMPA/kainate receptor antagonist
- Competitive non-NMDA receptor antagonist
- Blocks expression of fear-potentiated startle in rats
- Used in neurological disease research
- Targets iGluR
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC DNQX (FG 9041) | 2379-57-9 | C8H4N4O6 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
DNQX (FG 9041) is a quinoxaline derivative that functions as a selective, potent competitive non-NMDA glutamate receptor antagonist. It exhibits IC50 values of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors, respectively. This compound is known to selectively depolarize thalamic reticular nucleus (TRN) neurons.
- Selective, potent competitive non-NMDA glutamate receptor antagonist
- Exhibits IC50s of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors
- Selectively depolarizes thalamic reticular nucleus (TRN) neurons
- Purity of 99.67%
- Molecular weight of 252.14
- Appears as a white to off-white solid
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC NBQX (FG9202) | 118876-58-7 | C12H8N4O6S | 1 ML
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. It possesses neuroprotective and anticonvulsant activities. NBQX exhibits high affinity for AMPA and kainate binding sites, with minimal or no affinity for the glutamate recognition site on the NMDA receptor complex.
- Highly selective and competitive AMPA receptor antagonist
- Neuroprotective activity
- Anticonvulsant activity
- High affinity for AMPA and kainate binding sites
- Little to no affinity for the glutamate recognition site on the NMDA receptor complex
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Cnqx | 115066-14-3 | C9H4N4O4 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
CNQX is a potent and competitive AMPA/kainate receptor antagonist. It has IC50s of 0.3 μM for AMPA and 1.5 μM for kainate receptors, and also acts as a competitive non-NMDA receptor antagonist.
- Potent and competitive AMPA/kainate receptor antagonist
- IC50s of 0.3 μM for AMPA and 1.5 μM for kainate receptors
- Acts as a competitive non-NMDA receptor antagonist
- Blocks the expression of fear-potentiated startle in rats
- Reversibly blocks Schaffer collateral and mossy fibre excitatory postsynaptic potential (EPSP)
- Selectively reduces the amplitude of the monosynaptic component of DR-VRR
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 865-47-4 | Potassium tert-butoxide | Chem-Impex | MFCD00012162 | 112.213 | C4H9KO | 99.000 | [K+].CC(C)(C)[O-] | 25kg | 272388602
Potassium tert-butoxide | Chem-Impex | 865-47-4 | MFCD00012162 | 112.213 | C4H9KO | 99.000 | [K+].CC(C)(C)[O-] | 25kg | 272388602
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 865-47-4 | Potassium tert-butoxide | Oakwood Chemical | MFCD00012162 | 112.213 | C4H9KO | 99.000 | [K+].CC(C)(C)[O-] | 10kg | 537698672
Potassium tert-butoxide | Oakwood Chemical | 865-47-4 | MFCD00012162 | 112.213 | C4H9KO | 99.000 | [K+].CC(C)(C)[O-] | 10kg | 537698672
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More